A Double-Blind, Placebo-Controlled Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of LAMICTAL in Peds (1-24 months)

  • Fakhoury, Toufic (PI)
  • Baumann, Robert (CoI)
  • CIBULA, JEAN (CoI)
  • RIEL-ROMERO, ROSARIO (CoI)

Grants and Contracts Details

StatusFinished
Effective start/end date10/1/006/30/05

Funding

  • Glaxo Wellcome: $57,345.00